These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 487742)

  • 1. Prednimustine for prostate cancer therapy.
    Slack NH; Murphy GP
    Compr Ther; 1979 Sep; 5(9):54-7. PubMed ID: 487742
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    J Urol; 1979 Jun; 121(6):763-5. PubMed ID: 458947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New steroidal alkylating agents in advanced stage D carcinoma of the prostate.
    Mittelman A; Catane R; Murphy GP
    Cancer Treat Rep; 1977; 61(2):307-10. PubMed ID: 872134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
    Boesen E; Mouridsen HT
    Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined therapy of advanced prostatic carcinoma with estramustine and prednimustine.
    Catane R; Kaufman J; Mittelman A; Murphy GP
    J Urol; 1977 Mar; 117(3):332-5. PubMed ID: 839597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prednimustine: the rationale for clinical development.
    Schein PS; Cavalli F
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-2. PubMed ID: 3952515
    [No Abstract]   [Full Text] [Related]  

  • 9. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Prout GR; Schmidt JD; Soloway MS; Loening SA; Chu TM; Gaeta JF; Saroff J; Wajsman Z; Slack N; Scott WW
    Trans Am Assoc Genitourin Surg; 1978; 70():69-71. PubMed ID: 753026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednimustine in advanced breast cancer: a review.
    Mouridsen HT
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experiences in tumor-oriented anti-cancer drugs].
    Ohsawa N
    Nihon Naika Gakkai Zasshi; 1988 Mar; 77(3):313-7. PubMed ID: 2841390
    [No Abstract]   [Full Text] [Related]  

  • 14. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 15. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 16. Prednimustine in adult acute myeloid leukaemia.
    Brandt L; Könyves I
    Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
    Jensen HS; Hansen HH; Dombernowsky P
    Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with estramustine phosphate and predinimustine, two steroidal alkylating agents compounds [proceedings].
    Catane R
    Cancer Treat Rep; 1978 Aug; 62(8):1264-5. PubMed ID: 688269
    [No Abstract]   [Full Text] [Related]  

  • 19. Prednimustine.
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):1-44. PubMed ID: 3952516
    [No Abstract]   [Full Text] [Related]  

  • 20. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.